AbbVie (ABBV), adMare BioInnovations Name RIME Therapeutics as Biotech Innovators Award Winner

robot
Abstract generation in progress

AbbVie, in partnership with adMare BioInnovations, recognized RIME Therapeutics with the AbbVie Biotech Innovators Award for its innovative “Disruptide” platform. This award supports early-stage life science companies in Quebec and includes laboratory and office space, technical equipment access, and mentorship from AbbVie’s leadership. The collaboration aims to accelerate RIME Therapeutics’ drug discovery efforts in inflammatory and immunological diseases, fostering the growth of Canadian life sciences.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pinned